YD Bio Limited (YDES)

YD Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb 13, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	692	45	47	50
Market Cap Growth	1424.81%	-4.31%	-5.87%	-
Enterprise Value	689	43	-	-
Last Close Price	9.84	11.25	11.03	10.43
PE Ratio	-	-	3497.13	-
PS Ratio	21.10	88.92	135.44	138.36
PB Ratio	2.15	6.89	2062.32	5396.83
P/TBV Ratio	176.96	11.61	2062.32	5396.83
P/FCF Ratio	-	-	-	720.26
P/OCF Ratio	-	-	-	720.26
EV/Sales Ratio	1349.71	83.59	-	-
Debt / Equity Ratio	0.00	0.00	2.07	13.30
Debt / EBITDA Ratio	-	-	1.18	6.81
Debt / FCF Ratio	-	-	-	1.77
Net Debt / Equity Ratio	-0.47	-0.47	-1.72	10.07
Net Debt / EBITDA Ratio	2.29	2.29	5.34	-2.28
Net Debt / FCF Ratio	1.63	1.63	0.71	1.34
Asset Turnover	0.14	0.14	1.28	-
Inventory Turnover	6.65	6.65	3.64	-
Quick Ratio	12.91	12.91	0.62	0.40
Current Ratio	13.18	13.18	0.91	0.75
Return on Equity (ROE)	-42.69%	-42.69%	83.89%	-
Return on Assets (ROA)	-25.43%	-25.43%	-2.25%	-
Return on Invested Capital (ROIC)	-42.01%	-84.41%	-17.44%	-43.47%
Return on Capital Employed (ROCE)	-22.10%	-22.10%	-42.80%	-79.40%
Earnings Yield	-0.20%	-3.11%	0.03%	-0.10%
FCF Yield	-0.28%	-4.21%	-0.12%	0.14%
Buyback Yield / Dilution	-4.01%	-4.01%	-	-

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q